Brain and Behavior
A recent report indicates aspirin and non-steroidal antinflammatory drugs seem to have the positive and perhaps unexpected benefit, of cutting a person’s risk of developing AD.
In recent years, the government has made moves to support making the results of taxpayer-funded research available to taxpayers for free. A new bill in Congress attempts to pull the plug.
A recent article in the USA Today discussed “the placebo effect” and the debate surrounding it. According to the American Medical Association “a placebo is a substance provided to a patient that the physician believes has no specific pharmacological effect upon the condition being treated.” Perhaps more important to the understanding of the placebo effect is the belief of the patient.
It has been know for some time that aerobic exercise and physical activity helps to increase cognitive function and perhaps delay onset of Alzheimer’s disease. A recent study provides some explanation for how this might occur.
The world economic situation is fertile ground for anxiety, some realistic and other perpetuated from misinformation and personal agendas. According to the National Sleep Foundation, One-third of Americans are losing sleep over the state of the U.S. economy and other personal financial concerns.
As I wrote recently, Stephen Quake has been writing about conflicts of interest in research over at The Wild Side blog. He proposes solving these problems with peer review. I like the article, and he has many thoughtful things to say on the topic, but I don't really understand this proposal.
